Ultra-Low LDL Cholesterol May Not Help
Posted on: Tuesday, 3 October 2006, 18:00 CDT
U.S. researchers conducted an extensive review of the medical literature and found no clear evidence to support ultra-low targets for LDL cholesterol.
Experts have suggested that some very high-risk patients achieve an ultra-low LDL target of 70 milligrams/deciliter, even if it means having to take multiple medications.
However, a team of researchers from the VA Ann Arbor Healthcare System and the University of Michigan Health System did an exhaustive review of existing research on LDL cholesterol and heart health and conclude that there is no scientifically valid evidence to support the ultra-low LDL target of 70 milligrams/deciliter for very high-risk patients, according to the study in Annals of Internal Medicine.
Our review suggests that we in the medical community have misunderstood the scientific evidence on whether very low LDL is important, or whether adequate doses of statins are what is really important, says lead author Dr. Rodney Hayward.
Current practice guidelines and recommendations often focus on getting LDL as low as possible, but the literature to date doesn't demonstrate that low LDL is what is truly important -- but it does show that statins save lives in high cardiac risk patients regardless of a person's LDL level.
Source: United Press International
Related Articles
- CoreValve Announces That More Than 1,800 High-Risk Patients Have Been Treated With Its ReValving(R) System for Percutaneous Aortic Valve Replacement (PAVR)
- Mercy Merced Medical Center Selects Clinical Xpert CareFocus From Thomson Reuters for Identification of High-Risk Patients
- Previously Unrecognized Harm of Intensified Glucose Lowering Reported in High Risk Patients With Type 2 Diabetes
- CoreValve Announces That More Than 1,000 High-Risk Patients Have Been Treated With Its ReValving(R) System for Percutaneous Aortic Valve Replacement (PAVR)
- FDA Approves Noxafil(R) (Posaconazole) Oral Suspension For Prevention of Life-Threatening Fungal Infections In High-Risk Patients
- High-Risk U.S. Patients Lack Flu Shots
- PhRMA Expands Campaign to Educate Consumers on Risks of Importing Prescription Drugs
- Outpatient Care Compared With Hospitalization for Community- Acquired Pneumonia: A Randomized Trial in Low-Risk Patients
- Respiratory Viral Infections in High-Risk Patients
- CDC Flu Plan Protects High-Risk Patients
 |
 |
User Comments (0)
RSS Feeds